Latest Kidney Cancer News
Kidney Cancer News elsewhere on the Web
Martin H. Voss, MD, discusses the evaluation of nivolumab plus ipilimumab in IMDC-classified intermediate/poor-risk renal cell carcinoma.
Tang discusses the limitations in available data, but nonetheless high potential, of SBRT in kidney cancer.
Primary cilia are present on renal tubules and are implicated to play a pivotal role in transducing signals during development; however, the oncogenic role of cilia in clear cell renal cell carcinoma (ccRCC) has not been examined. Here we show that VHL wild-type ccRCC cell lines have a high ...
Purpose:Robot-assisted laparoscopic partial nephrectomy(RAPN) has become a key technology in the treatment of renal tumors.Effective preoperative planning an...
The prevalence of urological malignancies remains a significant global health concern, particularly given the challenging prognosis for patients in advanced disease stages. Consequently, there is a pressing need to explore the molecular mechanisms that regulate the development of urological ...
During a Case-Based Roundtable® event, Chandler Park, MD, moderated a discussion on how recent trial data and sites of metastasis affect treatment of favorable-risk metastatic clear cell renal cell carcinoma in the second article of a 2-part series.
In recent years, knowledge regarding immune regulation has expanded rapidly, and major advancements have been made in immunotherapy for immune-associated dis...
David Braun, MD, PhD, discusses how biomarkers are evolving for the treatment of renal cell carcinoma.
Jaime Merchan, MD, discusses what the potential clinical implications or takeaways for colleagues are based on findings from the phase 3 CLEAR study in advanced renal cell carcinoma (RCC).
Protein glycosylation may predict response to NIVO+CABO vs SUN in aRCC, with glycopeptides and complement proteins linked to progression-free survival and outcomes.
No results found.
Articles from Kidney Cancer UK
No results found.
No results found.